• Allogene Therapeutics, Inc. (NASDAQ:ALLO) Receives Consensus Recommendation of "Moderate Buy" from Analysts

    Источник: Buzz FX / 12 янв 2025 01:45:17   America/Chicago


    Allogene Therapeutics, Inc. (NASDAQ:ALLO) Receives Consensus Recommendation of "Moderate Buy" from Analysts Written by MarketBeat January 12, 2025 Share Link copied to clipboard. Shares of Allogene Therapeutics, Inc.
    Read more...
Опубликовать